1,150 records
How long has this drug been in shortage?
Across 1,150 records covering 1,147 package NDCs, days in shortage runs from 69 (0409-0801-01) to 5421 (24 package NDCs), and 1209 is the most common — 98 of them. Every value is transcribed from the source that states it and carries the sentence it was taken from: 285 sources across 1 site, last checked 2026-11-01, due for re-check by 2026-11-04. Every record has a page of its own, quoting the line that states it.
About this data
For every package FDA currently lists as in shortage: how long that shortage entry has been open (from openFDA's own `initial_posting_date` to today), what FDA says the package's supply is right now, and any recovery estimate FDA has given. What FDA itself publishes, checked directly on 2026-09-01 rather than assumed: the shortage list page (accessdata.fda.gov/scripts/drugshortages) shows which drugs are short and why and carries no date at all, while each per-drug detail page adds a single 'Date first posted' for the whole drug. Neither prints an elapsed duration, and neither gives the date per manufacturer. openFDA does — where several manufacturers report a shortage of the same drug, each carries its own posting date, and FDA's page shows only the earliest of them. Cross-checked across 30 drugs against those detail pages: 30 of 30 agreed, and in all 10 multi-manufacturer cases FDA's single date was exactly the earliest of ours. The underlying facts are FDA's own public-domain data; the duration is a computation over them that nobody publishes maintained, because it changes every day and hand-updating it was never worth the effort. A scheduled refetch of the same public API keeps it current for free. Read the duration next to `availability`, and do not read it alone: a shortage entry stays 'Current' until FDA resolves the whole shortage, so 63.8% of listed packages (746 of 1,169, measured 2026-09-01) are marked 'Available' even while their entry has been open for years — the median entry has been open 1,721 days and 1,118 of 1,169 have been open more than 1,000. Records cite a per-drug, per-manufacturer API query rather than a page offset, because openFDA's result ordering rotates daily and an offset URL stops containing its own record — see sources.txt. Source: https://api.fda.gov/drug/shortages.json (openFDA, no API key required at this volume). This is a monitored dataset, not a static page — stale_after_days is short and a build should re-run the fetch on a schedule rather than once.
The data
| Package NDC | Generic name | Manufacturer | Status | Availability now | Initial posting date | Last update date | Days in shortage | Dosage form | Therapeutic category | FDA note | Reason for shortage |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0009-0274-01 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Available | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | ||
| 0009-0280-02 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Unavailable | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | Next Delivery: November 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
| 0009-0280-03 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Limited Availability | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0009-0280-51 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Limited Availability | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
| 0009-0280-52 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Available | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | ||
| 0009-0306-02 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Available | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | ||
| 0009-0306-12 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Available | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | ||
| 0009-0775-26 | Clindamycin Phosphate Injection | Pfizer Inc. | Current | Unavailable | 03/21/2023 | 10/21/2026 | 1324 | Injection | Anti-Infective | Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0009-0870-26 | Clindamycin Phosphate Injection | Pfizer Inc. | Current | Unavailable | 03/21/2023 | 10/21/2026 | 1324 | Injection | Anti-Infective | Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0009-0902-18 | Clindamycin Phosphate Injection | Pfizer Inc. | Current | Unavailable | 03/21/2023 | 10/21/2026 | 1324 | Injection | Anti-Infective | Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0009-3073-01 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Limited Availability | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
| 0009-3073-03 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Limited Availability | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0009-3073-22 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Available | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | ||
| 0009-3073-23 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Available | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | ||
| 0009-3475-01 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Limited Availability | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | Limited Supply Available. Next Delivery and Estimated Recovery: December 2026 | Demand increase for the drug |
| 0009-3475-03 | Methylprednisolone Acetate Injection | Pfizer Inc. | Current | Limited Availability | 12/15/2021 | 10/21/2026 | 1785 | Injection | Rheumatology | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0037-0678-96 | Cromolyn Sodium Concentrate | Mylan Specialty, a Viatris Company | Current | Available | 11/03/2023 | 11/03/2026 | 1097 | Concentrate | Pulmonary/Allergy | ||
| 0053-6871-00 | Desmopressin Acetate Spray | Ferring | Current | Unavailable | 03/12/2021 | 05/01/2026 | 2063 | Spray | Hematology | Estimated recovery: TBD | Requirements related to complying with good manufacturing practices |
| 0054-0370-25 | Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Current | Limited Availability | 07/14/2023 | 10/14/2026 | 1209 | Capsule | Psychiatry | Available on allocation | Shortage of an active ingredient |
| 0054-0371-25 | Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Current | Limited Availability | 07/14/2023 | 10/14/2026 | 1209 | Capsule | Psychiatry | Available on allocation | Shortage of an active ingredient |
| 0054-0372-25 | Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Current | Limited Availability | 07/14/2023 | 10/14/2026 | 1209 | Capsule | Psychiatry | Available on allocation | Shortage of an active ingredient |
| 0054-0373-25 | Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Current | Limited Availability | 07/14/2023 | 10/14/2026 | 1209 | Capsule | Psychiatry | Available on allocation | Shortage of an active ingredient |
| 0054-0374-25 | Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Current | Limited Availability | 07/14/2023 | 10/14/2026 | 1209 | Capsule | Psychiatry | Available on allocation | Shortage of an active ingredient |
| 0054-0375-25 | Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Current | Limited Availability | 07/14/2023 | 10/14/2026 | 1209 | Capsule | Psychiatry | Available on allocation | Shortage of an active ingredient |
| 0054-0660-25 | Lisdexamfetamine Dimesylate Capsule | Hikma Pharmaceuticals USA, Inc. | Current | Limited Availability | 07/14/2023 | 05/12/2026 | 1209 | Capsule | Psychiatry | Available on allocation | Shortage of an active ingredient |
| 0054-3294-46 | Furosemide Oral Solution | Hikma Pharmaceuticals USA, Inc. | Current | Available | 03/31/2026 | 10/27/2026 | 218 | Oral Solution | Cardiovascular | ||
| 0054-3294-50 | Furosemide Oral Solution | Hikma Pharmaceuticals USA, Inc. | Current | Available | 03/31/2026 | 10/27/2026 | 218 | Oral Solution | Cardiovascular | ||
| 0054-3298-63 | Furosemide Oral Solution | Hikma Pharmaceuticals USA, Inc. | Current | Available | 03/31/2026 | 10/27/2026 | 218 | Oral Solution | Cardiovascular | ||
| 0068-0597-01 | Rifampin Injection | Sanofi-Aventis U.S. LLC | Current | Unavailable | 02/17/2021 | 09/18/2026 | 2086 | Injection | Anti-Infective | Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
| 0093-0832-01 | Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Current | Available | 03/10/2023 | 11/02/2026 | 1335 | Tablet | Neurology | ||
| 0093-0832-05 | Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Current | Available | 03/10/2023 | 11/02/2026 | 1335 | Tablet | Neurology | ||
| 0093-3212-01 | Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Current | Available | 03/10/2023 | 11/02/2026 | 1335 | Tablet | Neurology | ||
| 0093-3212-05 | Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Current | Available | 03/10/2023 | 11/02/2026 | 1335 | Tablet | Neurology | ||
| 0093-3213-01 | Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Current | Available | 03/10/2023 | 11/02/2026 | 1335 | Tablet | Neurology | ||
| 0093-3213-05 | Clonazepam Tablet | Teva Pharmaceuticals USA, Inc. | Current | Available | 03/10/2023 | 11/02/2026 | 1335 | Tablet | Neurology | ||
| 0143-9144-02 | Liraglutide Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 07/18/2023 | 10/14/2026 | 1205 | Injection | Endocrinology/Metabolism | ||
| 0143-9144-03 | Liraglutide Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 07/18/2023 | 10/14/2026 | 1205 | Injection | Endocrinology/Metabolism | ||
| 0143-9250-10 | Rocuronium Bromide Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 02/15/2023 | 10/14/2026 | 1358 | Injection | Anesthesia | Additional lots will be available. Product will be made available as it is released. | |
| 0143-9251-10 | Rocuronium Bromide Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 02/15/2023 | 10/14/2026 | 1358 | Injection | Anesthesia | Additional lots will be available. Product will be made available as it is released. | |
| 0143-9252-25 | Dopamine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 11/06/2017 | 10/14/2026 | 3285 | Injection | Cardiovascular | Product temporarily on backorder. Additional lots will be available in the February 2027 timeframe. | Demand increase for the drug |
| 0143-9254-25 | Dopamine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 11/06/2017 | 10/14/2026 | 3285 | Injection | Cardiovascular | Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
| 0143-9310-10 | Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 10/05/2022 | 10/14/2026 | 1491 | Injection | Anesthesia | Novaplus label | |
| 0143-9311-10 | Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 10/05/2022 | 10/14/2026 | 1491 | Injection | Anesthesia | Novaplus label | |
| 0143-9391-10 | Remifentanil Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 06/28/2022 | 10/14/2026 | 1590 | Injection | Analgesia/Addiction | Estimated recovery: TBD | Demand increase for the drug |
| 0143-9392-10 | Remifentanil Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 06/28/2022 | 10/14/2026 | 1590 | Injection | Analgesia/Addiction | Estimated recovery: TBD | Demand increase for the drug |
| 0143-9393-10 | Remifentanil Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 06/28/2022 | 10/14/2026 | 1590 | Injection | Analgesia/Addiction | Estimated recovery: TBD | Demand increase for the drug |
| 0143-9506-10 | Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 10/05/2022 | 10/14/2026 | 1491 | Injection | Anesthesia | Additional product will be made available as it is released. | |
| 0143-9507-10 | Etomidate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 10/05/2022 | 10/14/2026 | 1491 | Injection | Anesthesia | Additional product will be made available as it is released. | |
| 0143-9519-10 | Methotrexate Sodium Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 03/13/2023 | 10/14/2026 | 1332 | Injection | Rheumatology | Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
| 0143-9530-01 | Ifosfamide Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 06/12/2026 | 10/14/2026 | 145 | Injection | Oncology | Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
| 0143-9531-01 | Ifosfamide Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 06/12/2026 | 10/14/2026 | 145 | Injection | Oncology | Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
| 0143-9532-25 | Dexmedetomidine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 04/10/2020 | 10/14/2026 | 2399 | Injection | Anesthesia | Additional product will be made available as it is released. | |
| 0143-9575-10 | Lidocaine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 06/13/2018 | 10/14/2026 | 3066 | Injection | Anesthesia | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| 0143-9577-10 | Lidocaine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 06/13/2018 | 10/14/2026 | 3066 | Injection | Anesthesia | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| 0143-9594-25 | Lidocaine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 06/13/2018 | 10/14/2026 | 3066 | Injection | Anesthesia | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| 0143-9595-25 | Lidocaine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 06/13/2018 | 10/14/2026 | 3066 | Injection | Anesthesia | Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe. | Demand increase for the drug |
| 0143-9606-01 | Azacitidine Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 12/18/2020 | 10/14/2026 | 2147 | Injection | Oncology | Product temporarily on backorder. Additional lots will be available the end of October 2026. | Demand increase for the drug |
| 0143-9785-10 | Valproate Sodium Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 12/30/2020 | 10/14/2026 | 2135 | Injection | Neurology | Additional lots will be available. Product will be made available as it is released. | |
| 0143-9830-01 | Methotrexate Sodium Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 03/13/2023 | 10/14/2026 | 1332 | Injection | Rheumatology | Additional lots will be available in the November 2026 timeframe. Short Dated Prodcut Available. | Demand increase for the drug |
| 0143-9872-10 | Propranolol Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 10/31/2023 | 10/14/2026 | 1100 | Injection | Cardiovascular | Estimated recovery: TBD | Shortage of an active ingredient |
| 0143-9930-10 | Cefotaxime Sodium Powder, for Solution | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 02/17/2015 | 10/14/2026 | 4278 | Powder, For Solution | Anti-Infective | Estimated recovery: TBD | Demand increase for the drug |
| 0143-9931-25 | Cefotaxime Sodium Powder, for Solution | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 02/17/2015 | 10/14/2026 | 4278 | Powder, For Solution | Anti-Infective | Estimated recovery: TBD | Demand increase for the drug |
| 0143-9933-25 | Cefotaxime Sodium Powder, for Solution | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 02/17/2015 | 10/14/2026 | 4278 | Powder, For Solution | Anti-Infective | Estimated recovery: TBD | Demand increase for the drug |
| 0143-9935-01 | Cefotaxime Sodium Powder, for Solution | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 02/17/2015 | 10/14/2026 | 4278 | Powder, For Solution | Anti-Infective | Estimated recovery: TBD | Demand increase for the drug |
| 0169-2800-15 | Liraglutide Injection | Novo Nordisk, Inc. | Current | Limited Availability | 07/18/2023 | 09/22/2026 | 1205 | Injection | Endocrinology/Metabolism | Product will be available until discontinuation in January 2027 | Discontinuation of the manufacture of the drug |
| 0169-4060-12 | Liraglutide Injection | Novo Nordisk, Inc. | Current | Limited Availability | 07/18/2023 | 09/22/2026 | 1205 | Injection | Endocrinology/Metabolism | Estimated shortage duration: TBD | Delay in shipping of the drug |
| 0169-4060-13 | Liraglutide Injection | Novo Nordisk, Inc. | Current | Limited Availability | 07/18/2023 | 09/22/2026 | 1205 | Injection | Endocrinology/Metabolism | Estimated shortage duration: TBD | Delay in shipping of the drug |
| 0185-0842-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sandoz Inc. | Current | Available | 10/12/2022 | 10/21/2026 | 1484 | Tablet | Psychiatry | ||
| 0185-0853-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sandoz Inc. | Current | Available | 10/12/2022 | 10/21/2026 | 1484 | Tablet | Psychiatry | ||
| 0185-2098-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sandoz Inc. | Current | Available | 10/12/2022 | 10/21/2026 | 1484 | Tablet | Psychiatry | ||
| 0185-2099-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Sandoz Inc. | Current | Available | 10/12/2022 | 10/21/2026 | 1484 | Tablet | Psychiatry | ||
| 0264-1510-31 | Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Current | Available | 02/14/2022 | 10/19/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0264-1510-32 | Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Current | Available | 02/14/2022 | 10/19/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0264-1933-10 | Amino Acid Injection | B. Braun Medical Inc. | Current | Available | 12/08/2020 | 10/19/2026 | 2157 | Injection | Gastroenterology | ||
| 0264-2101-00 | Sterile Water Irrigant | B. Braun Medical Inc. | Current | Available | 04/28/2023 | 10/19/2026 | 1286 | Irrigant | Gastroenterology | ||
| 0264-2101-10 | Sterile Water Irrigant | B. Braun Medical Inc. | Current | Available | 04/28/2023 | 10/19/2026 | 1286 | Irrigant | Gastroenterology | ||
| 0264-4500-00 | Amino Acid Injection | B. Braun Medical Inc. | Current | Available | 12/08/2020 | 10/19/2026 | 2157 | Injection | Gastroenterology | ||
| 0264-4500-05 | Amino Acid Injection | B. Braun Medical Inc. | Current | Available | 12/08/2020 | 10/19/2026 | 2157 | Injection | Gastroenterology | ||
| 0264-7387-50 | Dextrose Monohydrate 70% Injection | B. Braun Medical Inc. | Current | Available | 10/11/2024 | 10/19/2026 | 754 | Injection | Endocrinology/Metabolism | ||
| 0264-7510-00 | Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Current | Available | 02/14/2022 | 10/19/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0264-7510-10 | Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Current | Available | 02/14/2022 | 10/19/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0264-7510-20 | Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Current | Available | 02/14/2022 | 10/19/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0264-7520-00 | Dextrose Monohydrate 10% Injection | B. Braun Medical Inc. | Current | Available | 03/01/2022 | 10/19/2026 | 1709 | Injection | Endocrinology/Metabolism | ||
| 0264-7520-10 | Dextrose Monohydrate 10% Injection | B. Braun Medical Inc. | Current | Available | 03/01/2022 | 10/19/2026 | 1709 | Injection | Endocrinology/Metabolism | ||
| 0264-7520-20 | Dextrose Monohydrate 10% Injection | B. Braun Medical Inc. | Current | Available | 03/01/2022 | 10/19/2026 | 1709 | Injection | Endocrinology/Metabolism | ||
| 0264-9594-10 | Lidocaine Hydrochloride Injection | B. Braun Medical Inc. | Current | Available | 10/25/2017 | 10/19/2026 | 3297 | Injection | Cardiovascular | ||
| 0264-9594-20 | Lidocaine Hydrochloride Injection | B. Braun Medical Inc. | Current | Available | 10/25/2017 | 10/19/2026 | 3297 | Injection | Cardiovascular | ||
| 0264-9598-20 | Lidocaine Hydrochloride Injection | B. Braun Medical Inc. | Current | Available | 10/25/2017 | 10/19/2026 | 3297 | Injection | Cardiovascular | ||
| 0264-9872-00 | Heparin Sodium Injection | B. Braun Medical Inc. | Current | Limited Availability | 11/14/2017 | 10/19/2026 | 3277 | Injection | Hematology | Estimated recovery: late Q4 2026; Manufacturing delays | Other |
| 0264-9872-10 | Heparin Sodium Injection | B. Braun Medical Inc. | Current | Limited Availability | 11/14/2017 | 10/19/2026 | 3277 | Injection | Hematology | Estimated recovery: late Q4 2026; Manufacturing delays | Other |
| 0338-0004-02 | Sterile Water Irrigant | Baxter Healthcare | Current | Available | 04/28/2023 | 11/03/2026 | 1286 | Irrigant | Gastroenterology | ||
| 0338-0004-03 | Sterile Water Irrigant | Baxter Healthcare | Current | Available | 04/28/2023 | 11/03/2026 | 1286 | Irrigant | Gastroenterology | ||
| 0338-0004-04 | Sterile Water Irrigant | Baxter Healthcare | Current | Limited Availability | 04/28/2023 | 10/16/2026 | 1286 | Irrigant | Gastroenterology | Estimated Recovery: January 2027 | Other |
| 0338-0017-02 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-03 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-10 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-11 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Unavailable | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | Estimated recovery: November 2026 | Demand increase for the drug |
| 0338-0017-18 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-31 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-38 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-41 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-48 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Unavailable | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | Estimated recovery: December 2026 | Demand increase for the drug |
| 0338-0023-02 | Dextrose Monohydrate 10% Injection | Baxter Healthcare | Current | Available | 03/01/2022 | 11/03/2026 | 1709 | Injection | Endocrinology/Metabolism | ||
| 0338-0023-03 | Dextrose Monohydrate 10% Injection | Baxter Healthcare | Current | Available | 03/01/2022 | 11/03/2026 | 1709 | Injection | Endocrinology/Metabolism | ||
| 0338-0023-04 | Dextrose Monohydrate 10% Injection | Baxter Healthcare | Current | Available | 03/01/2022 | 11/03/2026 | 1709 | Injection | Endocrinology/Metabolism | ||
| 0338-0069-10 | Ketorolac Tromethamine Injection | Baxter Healthcare | Current | Unavailable | 06/06/2018 | 11/03/2026 | 3073 | Injection | Analgesia/Addiction | Estimated recovery: December 2026 | Demand increase for the drug |
| 0338-0070-10 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0338-0072-25 | Ketorolac Tromethamine Injection | Baxter Healthcare | Current | Available | 06/06/2018 | 11/03/2026 | 3073 | Injection | Analgesia/Addiction | ||
| 0338-0074-30 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 07/20/2026 | 11/03/2026 | 107 | Injection | Endocrinology/Metabolism | ||
| 0338-0078-20 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0338-0409-03 | Lidocaine Hydrochloride Injection | Baxter Healthcare | Current | Available | 10/25/2017 | 11/03/2026 | 3297 | Injection | Cardiovascular | ||
| 0338-0411-02 | Lidocaine Hydrochloride Injection | Baxter Healthcare | Current | Available | 10/25/2017 | 11/03/2026 | 3297 | Injection | Cardiovascular | ||
| 0338-0431-03 | Heparin Sodium Injection | Baxter Healthcare | Current | Limited Availability | 11/14/2017 | 10/16/2026 | 3277 | Injection | Hematology | Estimated recovery: December 2026 | Demand increase for the drug |
| 0338-0433-04 | Heparin Sodium Injection | Baxter Healthcare | Current | Available | 11/14/2017 | 11/03/2026 | 3277 | Injection | Hematology | ||
| 0338-0499-06 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 11/03/2026 | 2157 | Injection | Gastroenterology | ||
| 0338-0502-03 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 11/03/2026 | 2157 | Injection | Gastroenterology | ||
| 0338-0502-06 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 11/03/2026 | 2157 | Injection | Gastroenterology | ||
| 0338-0551-11 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0338-0551-18 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0338-0644-03 | Amino Acid Injection | Baxter Healthcare | Current | Unavailable | 12/08/2020 | 11/03/2026 | 2157 | Injection | Gastroenterology | Estimated recovery: December 2026 | Shortage of an inactive ingredient component |
| 0338-0644-04 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 11/03/2026 | 2157 | Injection | Gastroenterology | ||
| 0338-0644-06 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 11/03/2026 | 2157 | Injection | Gastroenterology | ||
| 0338-0719-06 | Dextrose Monohydrate 70% Injection | Baxter Healthcare | Current | Available | 10/11/2024 | 11/03/2026 | 754 | Injection | Endocrinology/Metabolism | ||
| 0338-1005-02 | Dopamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 11/03/2026 | 3285 | Injection | Cardiovascular | ||
| 0338-1005-03 | Dopamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 11/03/2026 | 3285 | Injection | Cardiovascular | ||
| 0338-1007-02 | Dopamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 11/03/2026 | 3285 | Injection | Cardiovascular | ||
| 0338-1007-03 | Dopamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 10/16/2026 | 3285 | Injection | Cardiovascular | ||
| 0338-1055-48 | Metronidazole Injection | Baxter Healthcare | Current | Available | 01/13/2022 | 11/03/2026 | 1756 | Injection | Anti-Infective | ||
| 0338-1073-02 | Dobutamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 11/03/2026 | 3285 | Injection | Cardiovascular | ||
| 0338-1075-02 | Dobutamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 11/03/2026 | 3285 | Injection | Cardiovascular | ||
| 0338-1077-02 | Dobutamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 11/03/2026 | 3285 | Injection | Cardiovascular | ||
| 0338-1130-03 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 11/03/2026 | 2157 | Injection | Gastroenterology | ||
| 0338-1130-04 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 11/03/2026 | 2157 | Injection | Gastroenterology | ||
| 0338-1130-06 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 11/03/2026 | 2157 | Injection | Gastroenterology | ||
| 0338-3410-50 | Clindamycin Phosphate Injection | Baxter Healthcare | Current | Available | 03/21/2023 | 11/03/2026 | 1324 | Injection | Anti-Infective | ||
| 0338-3612-50 | Clindamycin Phosphate Injection | Baxter Healthcare | Current | Available | 03/21/2023 | 11/03/2026 | 1324 | Injection | Anti-Infective | ||
| 0338-3814-50 | Clindamycin Phosphate Injection | Baxter Healthcare | Current | Limited Availability | 03/21/2023 | 10/16/2026 | 1324 | Injection | Anti-Infective | Estimated recovery: December 2026 | Other |
| 0338-3991-01 | Ifosfamide Injection | Baxter Healthcare | Current | Available | 06/12/2026 | 11/03/2026 | 145 | Injection | Oncology | ||
| 0338-3993-01 | Ifosfamide Injection | Baxter Healthcare | Current | Available | 06/12/2026 | 11/03/2026 | 145 | Injection | Oncology | ||
| 0338-9545-50 | Clindamycin Phosphate Injection | Baxter Healthcare | Current | Available | 03/21/2023 | 11/03/2026 | 1324 | Injection | Anti-Infective | ||
| 0338-9549-50 | Clindamycin Phosphate Injection | Baxter Healthcare | Current | Available | 03/21/2023 | 10/16/2026 | 1324 | Injection | Anti-Infective | ||
| 0338-9553-50 | Clindamycin Phosphate Injection | Baxter Healthcare | Current | Available | 03/21/2023 | 11/03/2026 | 1324 | Injection | Anti-Infective | ||
| 0338-9555-24 | Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Current | Available | 04/10/2020 | 11/03/2026 | 2399 | Injection | Anesthesia | ||
| 0338-9557-12 | Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Current | Available | 04/10/2020 | 11/03/2026 | 2399 | Injection | Anesthesia | ||
| 0338-9664-40 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0338-9666-35 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 11/03/2026 | 1724 | Injection | Endocrinology/Metabolism | ||
| 0378-4415-01 | Flurazepam Hydrochloride Capsule | Rising Pharma Holdings, Inc. | Current | Unavailable | 08/03/2022 | 09/01/2026 | 1554 | Capsule | Neurology | Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility. | Regulatory delay |
| 0378-4430-01 | Flurazepam Hydrochloride Capsule | Rising Pharma Holdings, Inc. | Current | Unavailable | 08/03/2022 | 09/01/2026 | 1554 | Capsule | Neurology | Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility. | Regulatory delay |
| 0378-6854-77 | Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Current | Available | 07/14/2023 | 11/03/2026 | 1209 | Capsule | Psychiatry | ||
| 0378-6855-77 | Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Current | Available | 07/14/2023 | 11/03/2026 | 1209 | Capsule | Psychiatry | ||
| 0378-6856-77 | Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Current | Available | 07/14/2023 | 11/03/2026 | 1209 | Capsule | Psychiatry | ||
| 0378-6857-77 | Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Current | Available | 07/14/2023 | 11/03/2026 | 1209 | Capsule | Psychiatry | ||
| 0378-6858-77 | Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Current | Available | 07/14/2023 | 11/03/2026 | 1209 | Capsule | Psychiatry | ||
| 0378-6859-77 | Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Current | Available | 07/14/2023 | 11/03/2026 | 1209 | Capsule | Psychiatry | ||
| 0378-6860-77 | Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Current | Available | 07/14/2023 | 11/03/2026 | 1209 | Capsule | Psychiatry | ||
| 0406-5111-01 | Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Current | Available | 07/14/2023 | 08/20/2026 | 1209 | Capsule | Psychiatry | ||
| 0406-5112-01 | Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Current | Available | 07/14/2023 | 08/20/2026 | 1209 | Capsule | Psychiatry | ||
| 0406-5113-01 | Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Current | Available | 07/14/2023 | 08/20/2026 | 1209 | Capsule | Psychiatry | ||
| 0406-5114-01 | Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Current | Available | 07/14/2023 | 08/20/2026 | 1209 | Capsule | Psychiatry | ||
| 0406-5115-01 | Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Current | Available | 07/14/2023 | 08/20/2026 | 1209 | Capsule | Psychiatry | ||
| 0406-5116-01 | Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Current | Available | 07/14/2023 | 08/20/2026 | 1209 | Capsule | Psychiatry | ||
| 0406-5117-01 | Lisdexamfetamine Dimesylate Capsule | SpecGx LLC | Current | Available | 07/14/2023 | 08/20/2026 | 1209 | Capsule | Psychiatry | ||
| 0406-8884-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | SpecGx LLC | Current | Available | 10/12/2022 | 08/20/2026 | 1484 | Tablet | Psychiatry | ||
| 0406-8885-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | SpecGx LLC | Current | Available | 10/12/2022 | 08/20/2026 | 1484 | Tablet | Psychiatry | ||
| 0406-8891-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | SpecGx LLC | Current | Limited Availability | 10/12/2022 | 08/20/2026 | 1484 | Tablet | Psychiatry | Estimated recovery: TBD | Demand increase for the drug |
| 0406-8892-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | SpecGx LLC | Current | Limited Availability | 10/12/2022 | 08/20/2026 | 1484 | Tablet | Psychiatry | Estimated recovery: TBD | Demand increase for the drug |
| 0406-8893-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | SpecGx LLC | Current | Available | 10/12/2022 | 08/20/2026 | 1484 | Tablet | Psychiatry | ||
| 0406-8894-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | SpecGx LLC | Current | Limited Availability | 10/12/2022 | 08/20/2026 | 1484 | Tablet | Psychiatry | Estimated recovery: TBD | Demand increase for the drug |
| 0409-0001-25 | Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 04/02/2020 | 10/29/2026 | 2407 | Injection | Anesthesia | Limited Supply Available. Next Delivery: December 2026; Estimated Recovery: March 2027 | Demand increase for the drug |
| 0409-0024-10 | Sterile Water Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/23/2021 | 10/29/2026 | 1807 | Injection | Other | ||
| 0409-0025-10 | Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/06/2017 | 10/21/2026 | 3285 | Injection | Cardiovascular | ||
| 0409-0042-12 | Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/06/2017 | 10/21/2026 | 3285 | Injection | Cardiovascular | ||
| 0409-0151-10 | Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/06/2017 | 10/21/2026 | 3285 | Injection | Cardiovascular | ||
| 0409-0152-24 | Metronidazole Injection | InfoRLife SA | Current | Limited Availability | 01/13/2022 | 11/02/2026 | 1756 | Injection | Anti-Infective | Labeler: Hospira Inc. | Other |
| 0409-0155-02 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 10/21/2026 | 2399 | Injection | Anesthesia | ||
| 0409-0525-25 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | Historical NDC: 0409-1610-50 | |
| 0409-0801-01 | Pentostatin Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 08/27/2026 | 10/21/2026 | 69 | Injection | Oncology | Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-1005-20 | Heparin Sodium Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/14/2017 | 10/21/2026 | 3277 | Injection | Hematology | ||
| 0409-1100-10 | Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/06/2017 | 10/21/2026 | 3285 | Injection | Cardiovascular | ||
| 0409-1159-01 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1159-02 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1160-01 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1162-01 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1162-02 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1163-01 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1165-01 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1165-02 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1174-10 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 10/21/2026 | 2399 | Injection | Anesthesia | ||
| 0409-1176-30 | Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 05/30/2025 | 10/21/2026 | 523 | Injection | Analgesia/Addiction | ||
| 0409-1178-30 | Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 05/30/2025 | 10/21/2026 | 523 | Injection | Analgesia/Addiction | ||
| 0409-1181-30 | Meperidine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 05/30/2025 | 10/21/2026 | 523 | Injection | Analgesia/Addiction | ||
| 0409-1209-01 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-1283-31 | Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | ||
| 0409-1283-37 | Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-1304-31 | Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | ||
| 0409-1312-30 | Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | ||
| 0409-1312-36 | Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-1323-05 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-1403-10 | Rocuronium Bromide Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/15/2023 | 10/21/2026 | 1358 | Injection | Anesthesia | ||
| 0409-1434-01 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 10/21/2026 | 2399 | Injection | Anesthesia | ||
| 0409-1454-20 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 10/21/2026 | 2399 | Injection | Anesthesia | ||
| 0409-1530-01 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1541-10 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1596-10 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 10/21/2026 | 2399 | Injection | Anesthesia | ||
| 0409-1630-10 | Atropine Sulfate Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 01/01/2012 | 10/21/2026 | 5421 | Injection | Anesthesia | Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-1638-02 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 09/08/2026 | 2399 | Injection | Anesthesia | ||
| 0409-1660-20 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 09/21/2026 | 2399 | Injection | Anesthesia | ||
| 0409-1660-50 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 10/21/2026 | 2399 | Injection | Anesthesia | ||
| 0409-1746-10 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1746-30 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1749-10 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1749-29 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1752-50 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | Limited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-1755-50 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | ||
| 0409-1761-10 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-1761-62 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Analgesia/Addiction | ||
| 0409-1805-01 | Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 11/01/2017 | 10/21/2026 | 3290 | Injection | Analgesia/Addiction | Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-1858-12 | Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/06/2017 | 10/21/2026 | 3285 | Injection | Cardiovascular | ||
| 0409-1890-01 | Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | ||
| 0409-1890-23 | Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-1891-01 | Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | ||
| 0409-1893-01 | Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
| 0409-1896-20 | Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | Next Delivery: February 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-1985-30 | Lorazepam Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 05/03/2018 | 10/21/2026 | 3107 | Injection | Neurology | Limited Supply Available. Next Delivery and Estimated Recovery: June 2027 | Demand increase for the drug |
| 0409-2022-01 | Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | Next Delivery: February 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-2066-05 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-2222-12 | Heparin Sodium Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/14/2017 | 10/21/2026 | 3277 | Injection | Hematology | ||
| 0409-2253-01 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | Historical NDC: 0409-1582-29 | |
| 0409-2253-25 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | Historical NDC: 0409-1582-29 | |
| 0409-2305-05 | Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 04/02/2020 | 10/29/2026 | 2407 | Injection | Anesthesia | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: March 2027 | Demand increase for the drug |
| 0409-2305-17 | Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 04/02/2020 | 10/29/2026 | 2407 | Injection | Anesthesia | Next Estimated Delivery and Estimated Recovery: December 2026 | Demand increase for the drug |
| 0409-2305-50 | Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 04/02/2020 | 10/29/2026 | 2407 | Injection | Anesthesia | ||
| 0409-2308-01 | Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 04/02/2020 | 10/29/2026 | 2407 | Injection | Anesthesia | Next Delivery: November 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
| 0409-2308-02 | Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 04/02/2020 | 10/29/2026 | 2407 | Injection | Anesthesia | Next Delivery: November 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
| 0409-2308-49 | Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 04/02/2020 | 10/29/2026 | 2407 | Injection | Anesthesia | ||
| 0409-2308-50 | Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 04/02/2020 | 10/29/2026 | 2407 | Injection | Anesthesia | ||
| 0409-2344-01 | Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/06/2017 | 10/21/2026 | 3285 | Injection | Cardiovascular | ||
| 0409-2344-02 | Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/06/2017 | 10/21/2026 | 3285 | Injection | Cardiovascular | ||
| 0409-2344-88 | Dobutamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 11/06/2017 | 10/21/2026 | 3285 | Injection | Cardiovascular | Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-2510-01 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-2587-05 | Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 04/02/2020 | 10/29/2026 | 2407 | Injection | Anesthesia | Next Delivery: January 2027; Estimated Recovery: March 2027 | Demand increase for the drug |
| 0409-2596-03 | Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 04/02/2020 | 10/29/2026 | 2407 | Injection | Anesthesia | ||
| 0409-2596-05 | Midazolam Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 04/02/2020 | 10/29/2026 | 2407 | Injection | Anesthesia | ||
| 0409-2634-01 | Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | ||
| 0409-2634-05 | Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | ||
| 0409-2634-50 | Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | ||
| 0409-2815-01 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 10/21/2026 | 2399 | Injection | Anesthesia | ||
| 0409-3177-01 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3178-01 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3178-02 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Next Delivery: January 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3178-03 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Limited Supply Available. Next Delivery: April 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3181-01 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availalbility | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3182-01 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3182-02 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3182-03 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3183-01 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3189-10 | Rocuronium Bromide Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/15/2023 | 10/21/2026 | 1358 | Injection | Anesthesia | ||
| 0409-3299-05 | Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/03/2016 | 10/21/2026 | 3927 | Injection | Endocrinology/Metabolism | ||
| 0409-3299-06 | Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/03/2016 | 10/21/2026 | 3927 | Injection | Endocrinology/Metabolism | ||
| 0409-3299-25 | Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/03/2016 | 10/21/2026 | 3927 | Injection | Endocrinology/Metabolism | ||
| 0409-3299-26 | Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/03/2016 | 10/21/2026 | 3927 | Injection | Endocrinology/Metabolism | ||
| 0409-3301-10 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Limited Availability | 04/10/2020 | 10/21/2026 | 2399 | Injection | Anesthesia | Limited Supply Available. Next Delivery and Estimated Recovery: December 2026 | Other |
| 0409-3365-10 | Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | ||
| 0409-3382-21 | Sufentanil Citrate Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 05/03/2022 | 10/21/2026 | 1646 | Injection | Analgesia/Addiction | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3613-01 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-3793-01 | Ketorolac Tromethamine Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 03/26/2018 | 10/21/2026 | 3145 | Injection | Analgesia/Addiction | Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3795-01 | Ketorolac Tromethamine Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 03/26/2018 | 10/21/2026 | 3145 | Injection | Analgesia/Addiction | Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3796-01 | Ketorolac Tromethamine Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 03/26/2018 | 10/21/2026 | 3145 | Injection | Analgesia/Addiction | Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3812-01 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | ||
| 0409-3814-12 | Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | ||
| 0409-3815-12 | Morphine Sulfate Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 10/31/2017 | 10/21/2026 | 3291 | Injection | Analgesia/Addiction | Limited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-3977-03 | Sterile Water Injection | Hospira, Inc., a Pfizer Company | Current | Available | 12/03/2021 | 10/29/2026 | 1797 | Injection | Other | ||
| 0409-4208-10 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | ||
| 0409-4264-01 | Hydromorphone Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 11/01/2017 | 10/21/2026 | 3290 | Injection | Analgesia/Addiction | Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-4275-01 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-4276-01 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-4276-02 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-4277-01 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-4277-02 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-4278-01 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-4279-02 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-4282-01 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-4282-02 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-4283-01 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-4596-20 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 10/21/2026 | 2399 | Injection | Anesthesia | ||
| 0409-4713-02 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-4713-32 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | Next Delivery and Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-4776-01 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-4887-10 | Sterile Water Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/23/2021 | 10/29/2026 | 1807 | Injection | Other | ||
| 0409-4887-20 | Sterile Water Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/23/2021 | 10/29/2026 | 1807 | Injection | Other | ||
| 0409-4887-50 | Sterile Water Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/23/2021 | 10/29/2026 | 1807 | Injection | Other | ||
| 0409-4887-99 | Sterile Water Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/23/2021 | 10/29/2026 | 1807 | Injection | Other | ||
| 0409-5010-01 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-5160-10 | Rocuronium Bromide Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/15/2023 | 10/21/2026 | 1358 | Injection | Anesthesia | ||
| 0409-5555-01 | Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Current | Limited Supply Available. Next Delivery and Estimated Recovery: June 2027 | 03/01/2017 | 10/21/2026 | 3535 | Injection | Endocrinology/Metabolism | Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-5555-02 | Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 03/01/2017 | 10/21/2026 | 3535 | Injection | Endocrinology/Metabolism | Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027 | Demand increase for the drug |
| 0409-5738-10 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | ||
| 0409-5820-01 | Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 11/06/2017 | 10/21/2026 | 3285 | Injection | Cardiovascular | ||
| 0409-6102-02 | Furosemide Injection | Hospira, Inc., a Pfizer Company | Current | Available | 04/07/2020 | 10/21/2026 | 2402 | Injection | Cardiovascular | ||
| 0409-6102-04 | Furosemide Injection | Hospira, Inc., a Pfizer Company | Current | Available | 04/07/2020 | 10/21/2026 | 2402 | Injection | Cardiovascular | ||
| 0409-6102-10 | Furosemide Injection | Hospira, Inc., a Pfizer Company | Current | Available | 04/07/2020 | 10/21/2026 | 2402 | Injection | Cardiovascular | ||
| 0409-6102-25 | Furosemide Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 04/07/2020 | 10/21/2026 | 2402 | Injection | Cardiovascular | Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-6102-26 | Furosemide Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 04/07/2020 | 10/21/2026 | 2402 | Injection | Cardiovascular | Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-6102-27 | Furosemide Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 04/07/2020 | 10/21/2026 | 2402 | Injection | Cardiovascular | Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-6581-01 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | ||
| 0409-6625-14 | Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 03/01/2017 | 10/21/2026 | 3535 | Injection | Endocrinology/Metabolism | ||
| 0409-6625-35 | Sodium Bicarbonate Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 03/01/2017 | 10/21/2026 | 3535 | Injection | Endocrinology/Metabolism | Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-6648-02 | Dextrose Monohydrate 50% Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 01/13/2022 | 10/27/2026 | 1756 | Injection | Endocrinology/Metabolism | Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-6695-01 | Etomidate Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 10/05/2022 | 10/21/2026 | 1491 | Injection | Anesthesia | Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-6695-02 | Etomidate Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 10/05/2022 | 10/21/2026 | 1491 | Injection | Anesthesia | Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-7037-10 | Rocuronium Bromide Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/15/2023 | 10/21/2026 | 1358 | Injection | Anesthesia | ||
| 0409-7299-25 | Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/03/2016 | 10/21/2026 | 3927 | Injection | Endocrinology/Metabolism | ||
| 0409-7299-73 | Sodium Acetate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/03/2016 | 10/21/2026 | 3927 | Injection | Endocrinology/Metabolism | ||
| 0409-7517-16 | Dextrose Monohydrate 50% Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 01/13/2022 | 10/27/2026 | 1756 | Injection | Endocrinology/Metabolism | Next Delivery: November 2026. Estimated Recovery: March 2027. Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-7535-01 | Bupivacaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/21/2026 | 3179 | Injection | Anesthesia | ||
| 0409-7809-24 | Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 11/06/2017 | 10/21/2026 | 3285 | Injection | Cardiovascular | Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-7838-24 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 10/21/2026 | 2399 | Injection | Anesthesia | ||
| 0409-7853-24 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 10/21/2026 | 2399 | Injection | Anesthesia | ||
| 0409-7875-12 | Dexmedetomidine Hydrochloride Injection | Pfizer Inc. | Current | Available | 04/10/2020 | 09/21/2026 | 2399 | Injection | Anesthesia | ||
| 0409-8126-10 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/20/2018 | 10/29/2026 | 3179 | Injection | Analgesia/Addiction | ||
| 0409-9042-01 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-9042-17 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-9043-01 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-9045-01 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-9045-17 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-9046-01 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Hospira, Inc., a Pfizer Company | Current | Unavailable | 02/20/2018 | 10/29/2026 | 3179 | Injection | Anesthesia | Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-9094-22 | Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 01/01/2012 | 10/21/2026 | 5421 | Injection | Analgesia/Addiction | ||
| 0409-9094-25 | Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 01/01/2012 | 10/21/2026 | 5421 | Injection | Analgesia/Addiction | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
| 0409-9094-28 | Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 01/01/2012 | 10/21/2026 | 5421 | Injection | Analgesia/Addiction | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
| 0409-9094-31 | Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 01/01/2012 | 10/21/2026 | 5421 | Injection | Analgesia/Addiction | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
| 0409-9094-55 | Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 01/01/2012 | 10/21/2026 | 5421 | Injection | Analgesia/Addiction | ||
| 0409-9094-61 | Fentanyl Citrate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 01/01/2012 | 10/21/2026 | 5421 | Injection | Analgesia/Addiction | ||
| 0409-9104-20 | Dopamine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Limited Availability | 11/06/2017 | 10/21/2026 | 3285 | Injection | Cardiovascular | Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| 0409-9137-05 | Lidocaine Hydrochloride Injection | Hospira, Inc., a Pfizer Company | Current | Available | 02/22/2012 | 10/21/2026 | 5369 | Injection | Anesthesia | ||
| 0409-9630-05 | Atropine Sulfate Injection | Hospira, Inc., a Pfizer Company | Current | Available | 01/01/2012 | 10/21/2026 | 5421 | Injection | Anesthesia | ||
| 0480-3564-01 | Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Current | Available | 07/14/2023 | 11/02/2026 | 1209 | Capsule | Psychiatry | ||
| 0480-3565-01 | Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Current | Available | 07/14/2023 | 11/02/2026 | 1209 | Capsule | Psychiatry | ||
| 0480-3566-01 | Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Current | Available | 07/14/2023 | 11/02/2026 | 1209 | Capsule | Psychiatry | ||
| 0480-3567-01 | Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Current | Available | 07/14/2023 | 11/02/2026 | 1209 | Capsule | Psychiatry | ||
| 0480-3568-01 | Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Current | Available | 07/14/2023 | 11/02/2026 | 1209 | Capsule | Psychiatry | ||
| 0480-3569-01 | Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Current | Available | 07/14/2023 | 11/02/2026 | 1209 | Capsule | Psychiatry | ||
| 0480-3570-01 | Lisdexamfetamine Dimesylate Capsule | Teva Pharmaceuticals USA, Inc. | Current | Available | 07/14/2023 | 11/02/2026 | 1209 | Capsule | Psychiatry | ||
| 0480-3667-20 | Liraglutide Injection | Novo Nordisk, Inc. | Current | Available | 07/18/2023 | 09/22/2026 | 1205 | Injection | Endocrinology/Metabolism | Distributed by Teva | |
| 0480-3667-22 | Liraglutide Injection | Novo Nordisk, Inc. | Current | Available | 07/18/2023 | 09/22/2026 | 1205 | Injection | Endocrinology/Metabolism | Distributed by Teva | |
| 0487-6105-01 | Sterile Water Injection | Nephron Pharmaceuticals Corporation | Current | Limited Availability | 11/23/2021 | 08/04/2026 | 1807 | Injection | Other | Small amount of inventory available with 12/31/2026 dating | Other |
| 0517-1001-25 | Atropine Sulfate Injection | American Regent, Inc. | Current | Available | 01/01/2012 | 11/03/2026 | 5421 | Injection | Anesthesia | ||
| 0517-1004-25 | Atropine Sulfate Injection | American Regent, Inc. | Current | Available | 01/01/2012 | 11/03/2026 | 5421 | Injection | Anesthesia | On allocation | |
| 0527-0760-37 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Current | Available | 10/12/2022 | 11/02/2026 | 1484 | Tablet | Psychiatry | ||
| 0527-0761-37 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Current | Available | 10/12/2022 | 11/02/2026 | 1484 | Tablet | Psychiatry | ||
| 0527-0763-37 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Current | Available | 10/12/2022 | 11/02/2026 | 1484 | Tablet | Psychiatry | ||
| 0527-0764-37 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Current | Available | 10/12/2022 | 11/02/2026 | 1484 | Tablet | Psychiatry | ||
| 0527-0766-37 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Current | Available | 10/12/2022 | 10/15/2026 | 1484 | Tablet | Psychiatry | ||
| 0527-1502-37 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Current | Available | 10/12/2022 | 11/02/2026 | 1484 | Tablet | Psychiatry | ||
| 0527-1505-37 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Lannett Company, Inc. | Current | Available | 10/12/2022 | 11/02/2026 | 1484 | Tablet | Psychiatry | ||
| 0527-4661-37 | Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Current | Available | 07/14/2023 | 11/02/2026 | 1209 | Capsule | Psychiatry | ||
| 0527-4662-37 | Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Current | Limited Availability | 07/14/2023 | 10/15/2026 | 1209 | Capsule | Psychiatry | Estimated recovery: October 2026 | Other |
| 0527-4663-37 | Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Current | Limited Availability | 07/14/2023 | 10/15/2026 | 1209 | Capsule | Psychiatry | Estimated recovery: October 2026 | Other |
| 0527-4664-37 | Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Current | Limited Availability | 07/14/2023 | 10/15/2026 | 1209 | Capsule | Psychiatry | Estimated recovery: October 2026 | Other |
| 0527-4665-37 | Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Current | Available | 07/14/2023 | 11/02/2026 | 1209 | Capsule | Psychiatry | ||
| 0527-4666-37 | Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Current | Available | 09/20/2023 | 11/02/2026 | 1141 | Capsule | Psychiatry | ||
| 0527-4667-37 | Lisdexamfetamine Dimesylate Capsule | Lannett Company, Inc. | Current | Available | 07/14/2023 | 11/02/2026 | 1209 | Capsule | Psychiatry | ||
| 0555-0775-02 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Current | Available | 10/12/2022 | 11/02/2026 | 1484 | Tablet | Psychiatry | ||
| 0555-0776-02 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Current | Available | 10/12/2022 | 11/02/2026 | 1484 | Tablet | Psychiatry | ||
| 0555-0777-02 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Current | Available | 10/12/2022 | 11/02/2026 | 1484 | Tablet | Psychiatry | ||
| 0555-0971-02 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Current | Available | 10/12/2022 | 11/02/2026 | 1484 | Tablet | Psychiatry | ||
| 0555-0972-02 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Current | Available | 10/12/2022 | 11/02/2026 | 1484 | Tablet | Psychiatry | ||
| 0555-0973-02 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Current | Available | 10/12/2022 | 11/02/2026 | 1484 | Tablet | Psychiatry | ||
| 0555-0974-02 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Teva Pharmaceuticals USA, Inc. | Current | Limited Availability | 10/12/2022 | 10/15/2026 | 1484 | Tablet | Psychiatry | Estimated recovery: TBD | Other |
| 0574-2410-65 | Methylphenidate Film, Extended Release | Noven Pharmaceuticals, Inc. | Current | Available | 02/28/2025 | 10/16/2026 | 614 | Film, Extended Release | Psychiatry | Distributed by Padagis US LLC | |
| 0574-2415-65 | Methylphenidate Film, Extended Release | Noven Pharmaceuticals, Inc. | Current | Available | 02/28/2025 | 10/16/2026 | 614 | Film, Extended Release | Psychiatry | Distributed by Padagis US LLC | |
| 0574-2420-65 | Methylphenidate Film, Extended Release | Noven Pharmaceuticals, Inc. | Current | Available | 02/28/2025 | 10/16/2026 | 614 | Film, Extended Release | Psychiatry | Distributed by Padagis US LLC | |
| 0574-2430-65 | Methylphenidate Film, Extended Release | Noven Pharmaceuticals, Inc. | Current | Available | 02/28/2025 | 10/16/2026 | 614 | Film, Extended Release | Psychiatry | Distributed by Padagis US LLC | |
| 0574-4022-35 | Bacitracin Ophthalmic Ointment | Padagis US LLC | Current | Unavailable | 03/03/2025 | 10/23/2026 | 611 | Ophthalmic Ointment | Anti-Infective | Shortage is estimated for 15 additional months | Discontinuation of the manufacture of the drug |
| 0591-2888-30 | Hydroxocobalamin Injection | Teva Pharmaceuticals USA, Inc. | Current | Unavailable | 11/04/2024 | 11/02/2026 | 730 | Injection | Other | Estimated recovery: mid-November 2026 | Other |
| 0641-0121-25 | Hydromorphone Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 11/03/2017 | 10/14/2026 | 3288 | Injection | Analgesia/Addiction | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| 0641-0367-25 | Dexamethasone Sodium Phosphate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 02/08/2019 | 10/14/2026 | 2826 | Injection | Dermatology | Product will be made available as it is released. | |
| 0641-0928-25 | Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 11/21/2023 | 10/14/2026 | 1079 | Injection | Analgesia/Addiction | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| 0641-0929-25 | Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 11/21/2023 | 10/14/2026 | 1079 | Injection | Analgesia/Addiction | Estimated recovery: TBD | Demand increase for the drug |
| 0641-1495-35 | Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 11/21/2023 | 10/14/2026 | 1079 | Injection | Analgesia/Addiction | Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
| 0641-1496-35 | Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 11/21/2023 | 10/14/2026 | 1079 | Injection | Analgesia/Addiction | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| 0641-6000-10 | Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 09/05/2018 | 10/14/2026 | 2982 | Injection | Neurology | Estimated recovery: TBD | Other |
| 0641-6001-25 | Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Current | Limited Availability | 09/05/2018 | 10/14/2026 | 2982 | Injection | Neurology | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Demand increase for the drug |
| 0641-6002-10 | Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 09/05/2018 | 10/14/2026 | 2982 | Injection | Neurology | Estimated recovery: TBD | Other |
| 0641-6003-25 | Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Current | Limited Availability | 09/05/2018 | 10/14/2026 | 2982 | Injection | Neurology | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Demand increase for the drug |
| 0641-6019-10 | Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 11/03/2017 | 10/14/2026 | 3288 | Injection | Analgesia/Addiction | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| 0641-6020-10 | Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 11/03/2017 | 10/14/2026 | 3288 | Injection | Analgesia/Addiction | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| 0641-6024-10 | Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 12/20/2023 | 10/14/2026 | 1050 | Injection | Analgesia/Addiction | Inventory available in vial presentations. | Other |
| 0641-6025-10 | Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 12/20/2023 | 10/14/2026 | 1050 | Injection | Analgesia/Addiction | Inventory available in vial presentations. | Other |
| 0641-6026-05 | Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 12/20/2023 | 10/14/2026 | 1050 | Injection | Analgesia/Addiction | Inventory available in vial presentations. | Other |
| 0641-6027-25 | Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 12/20/2023 | 10/14/2026 | 1050 | Injection | Analgesia/Addiction | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| 0641-6028-25 | Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 12/20/2023 | 10/14/2026 | 1050 | Injection | Analgesia/Addiction | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| 0641-6029-25 | Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 12/20/2023 | 10/14/2026 | 1050 | Injection | Analgesia/Addiction | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| 0641-6030-01 | Fentanyl Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 12/20/2023 | 10/14/2026 | 1050 | Injection | Analgesia/Addiction | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| 0641-6039-01 | Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 11/03/2017 | 10/14/2026 | 3288 | Injection | Analgesia/Addiction | Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
| 0641-6040-01 | Morphine Sulfate Injection | Hikma Pharmaceuticals USA, Inc. | Current | Available | 11/03/2017 | 10/14/2026 | 3288 | Injection | Analgesia/Addiction | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| 0641-6041-25 | Ketorolac Tromethamine Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 06/06/2018 | 10/14/2026 | 3073 | Injection | Analgesia/Addiction | Estimated recovery: TBD | Other |
| 0641-6042-25 | Ketorolac Tromethamine Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 06/06/2018 | 10/14/2026 | 3073 | Injection | Analgesia/Addiction | Estimated recovery: TBD | Other |
| 0641-6043-25 | Ketorolac Tromethamine Injection | Hikma Pharmaceuticals USA, Inc. | Current | Unavailable | 06/06/2018 | 10/14/2026 | 3073 | Injection | Analgesia/Addiction | Estimated recovery: TBD | Other |
| 0641-6044-25 | Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Current | Limited Availability | 09/05/2018 | 10/14/2026 | 2982 | Injection | Neurology | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Demand increase for the drug |
| 0641-6045-25 | Lorazepam Injection | Hikma Pharmaceuticals USA, Inc. | Current | Limited Availability | 09/05/2018 | 10/14/2026 | 2982 | Injection | Neurology | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Demand increase for the drug |
Showing the first 400 of 1,150 records. Every record has its own page, with its source and the quoted line that states it; these list the rest.
- Records 1–4000009-0274-01 · Methylprednisolone Acetate Injection · Pfizer Inc. … 0641-6045-25 · Lorazepam Injection · Hikma Pharmaceuticals USA, Inc.
- Records 401–8000641-6046-10 · Lorazepam Injection · Hikma Pharmaceuticals USA, Inc. … 63323-162-01 · Ketorolac Tromethamine Injection · Fresenius Kabi USA, LLC
- Records 801–1,15063323-162-02 · Ketorolac Tromethamine Injection · Fresenius Kabi USA, LLC … 84383-110-01 · Penicillin G Benzathine Injection · Laboratorios Atral
Where this came from
Every record above links the page it was taken from and quotes the sentence that states it. These are the 285 sources this dataset was assembled from.
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Specialty,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ferring%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sanofi-Aventis%20U.S.%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Valproate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Propranolol%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rising%20Pharma%20Holdings,%20Inc.%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Pharmaceuticals%20Inc.,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Pentostatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sufentanil%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Nephron%20Pharmaceuticals%20Corporation%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22American%20Regent,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Noven%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Film,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Padagis%20US%20LLC%22+AND+generic_name%3A%22Bacitracin%20Ophthalmic%20Ointment%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydroxocobalamin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Streptozocin%20Powder,%20For%20Solution%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Jiangsu%20Hengrui%20Pharmaceuticals%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sunrise%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Trigen%20Laboratories,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rising%20Pharma%20Holdings,%20Inc.%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sufentanil%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aspiro%20Pharma%20Limited%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22XGen%20Pharmaceuticals%20DJB,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22XGen%20Pharmaceuticals%20DJB,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Micro%20Labs%20LTD%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rhodes%20Pharmaceuticals%20L.P.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Prinston%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Dr.%20Reddy%27s%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22HQ%20Specialty%20Pharma%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22WG%20Critical%20Care%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Technetium%20TC-99M%20Pyrophosphate%20Kit%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fera%20Pharmaceuticals%22+AND+generic_name%3A%22Echothiophate%20Iodide%20Ophthalmic%20Solution%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Janssen%20Pharmaceuticals%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22BTG%20International%20Inc.%22+AND+generic_name%3A%22Hydroxocobalamin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Exela%20Pharma%20Sciences,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Azurity%20Pharmaceuticals,%20Inc%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medexus%22+AND+generic_name%3A%22Triamcinolone%20Hexacetonide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Bristol%20Myers%20Squibb%20Co.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Penicillin%20G%20Benzathine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Cheplapharm%20Arzneimittel%20GmbH%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alembic%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Valproate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Propranolol%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medefil,%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medefil,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Spectra%20Medical%20Devices,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Cumberland%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Conivaptan%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Piramal%20Critical%20Care%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Piramal%20Critical%20Care%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22ESTEVE%20PHARMACEUTICALS,%20S.A.%22+AND+generic_name%3A%22Streptozocin%20Powder,%20For%20Solution%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teyro%20Labs%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ailex%20Pharmaceuticals%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Curium%20US%20LLC%22+AND+generic_name%3A%22Technetium%20TC-99M%20Pyrophosphate%20Kit%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Granules%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hainan%20Poly%20Pharm.%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22EDW%20Pharma,%20Inc.%20(formerly%20Italfarmaco%20Pharma,%20Inc.)%22+AND+generic_name%3A%22Riluzole%20Oral%20Suspension%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Kindos%20Pharmaceuticals%20Co.%20Ltd.%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Milla%20Pharmaceuticals%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novadoz%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22ONESOURCE%20SPECIALTY%20PTE%20LTD%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lifsa%20Drugs%20LLC%22+AND+generic_name%3A%22Isocarboxazid%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Armas%20Pharmaceuticals%20Inc%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Oryza%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Huons%20Co.,%20Ltd.%20(South%20Korea)%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Huons%20Co.,%20Ltd%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Long%20Grove%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Jiangsu%20Hengrui%20Pharmaceuticals%20Co.%20(US%20Agent%20eVenus%20Pharmaceutical%20Laboratories,%20Inc.)%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Anthea%20Pharma%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avyxa%20Pharma,%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Laboratorios%20Atral%22+AND+generic_name%3A%22Penicillin%20G%20Benzathine%20Injection%22+AND+status%3A%22Current%22&limit=1000
Machine-readable
- data.jsonThe whole dataset — every record with its source URL and source quote.
- Open Knowledge Format bundleOne JSON object per line — every record's frontmatter and quoted span exactly as it is held here, in one fetch.
- data.csvThe same records as one flat table, for a spreadsheet or a dataframe. The last four columns are the source URL, the quoted sentence it was read from, the date we last checked it, and which columns are our reading rather than the page's words.
- How this is made and checkedWhat "verified against source" does and does not mean.
From your own code
Same records, same quotes, without scraping the page: refsource is on PyPI and npm. Each value comes back carrying the URL it was read from and the sentence on that page that states it — .source and .quote sit on the value itself rather than in a side channel, so the checking step is available instead of skipped.
pip install refsource
refsource lookup drug-shortage-duration-tracker generic_name="Methylprednisolone Acetate Injection"
npx -y refsource lookup drug-shortage-duration-tracker generic_name="Methylprednisolone Acetate Injection"
Set your AI assistant up to use this
Two files and no account. Put this in .mcp.json at the root of your project — Claude Code, Cursor, Windsurf, VS Code and Codex all read that file — and your assistant can look this dataset up instead of recalling it. The server is remote, keyless and read-only.
{
"mcpServers": {
"referencesource": {
"type": "http",
"url": "https://referencesource.org/mcp"
}
}
}Add to Cursor · or, on the command line: claude mcp add --transport http referencesource https://referencesource.org/mcp --scope project
Then one line in the project's CLAUDE.md or AGENTS.md, so the assistant knows when to reach for it:
When a question needs "FDA drug shortage duration tracker", call the referencesource MCP server at https://referencesource.org/mcp (tool `search_records`, dataset_slug `drug-shortage-duration-tracker`) instead of answering from memory — every record it returns carries its source URL and a verbatim quote from that page.What each tool does, and the servers built over single registers: Connect your AI assistant.